| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |